Hepatitis C Virus NS5A Inhibitor [EPC] class drugs

7 results

  • epclusa - velpatasvir and sofosbuvir tablet, film coated

    (Velpatasvir And Sofosbuvir)
    Gilead Sciences, Inc.
    Epclusa treats chronic hepatitis C virus (HCV) genotypes 1–6 in adults and children aged 3 and older. It is used with or without cirrhosis; patients with decompensated cirrhosis take it in combination with ribavirin.
    Medication Details
    Drug Interactions

  • harvoni - ledipasvir and sofosbuvir tablet, film coated

    (Ledipasvir And Sofosbuvir)
    Gilead Sciences, Inc
    Harvoni treats chronic hepatitis C virus (HCV) in adults and pediatric patients aged 3 and older with genotype 1, 4, 5, or 6 infection, with or without cirrhosis. Used with ribavirin for decompensated cirrhosis or liver transplant recipients with genotype 1 or 4 infection.
    Medication Details
    Drug Interactions

  • mavyret - glecaprevir and pibrentasvir tablet, film coated

    (Glecaprevir And Pibrentasvir)
    Abbvie Inc.
    Mavyret treats acute or chronic hepatitis C (genotypes 1–6) in adults and children 3+ without cirrhosis or with compensated cirrhosis. Also indicated for genotype 1 patients previously treated with an NS5A inhibitor or NS3/4A protease inhibitor (but not both).
    Medication Details
    Drug Interactions

  • vosevi - sofosbuvir, velpatasvir, and voxilaprevir tablet, film coated

    (Sofosbuvir, Velpatasvir, And Voxilaprevir)
    Gilead Sciences, Inc.
    Vosevi treats chronic hepatitis C (genotypes 1–6) in adults without cirrhosis or with compensated cirrhosis who were previously treated with an NS5A inhibitor, or genotype 1a/3 patients previously treated with sofosbuvir without an NS5A inhibitor.
    Medication Details
    Drug Interactions